Found 5 hits for monomerid = 287528 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM287528
(8-(2-((1-acryloylazetidin-3-yl)oxy)ethyl)-6-(2,6-d...)Show SMILES CCN1CCN(CCNc2ncc3cc(-c4c(Cl)c(OC)cc(OC)c4Cl)c(=O)n(CCOC4CN(C4)C(=O)C=C)c3n2)CC1 |(-5.61,-8.47,;-6.94,-7.7,;-6.94,-6.16,;-8.28,-5.39,;-8.28,-3.85,;-6.94,-3.08,;-6.94,-1.54,;-5.61,-.77,;-5.61,.77,;-4.28,1.54,;-4.28,3.08,;-2.94,3.85,;-1.61,3.08,;-.28,3.85,;1.06,3.08,;2.39,3.85,;2.39,5.39,;1.06,6.16,;3.72,6.16,;3.72,7.7,;5.06,8.47,;5.06,5.39,;5.06,3.85,;6.39,3.08,;7.73,3.85,;3.72,3.08,;3.72,1.54,;1.06,1.54,;2.39,.77,;-.28,.77,;-.28,-.77,;1.06,-1.54,;1.06,-3.08,;2.39,-3.85,;2.79,-5.34,;4.28,-4.94,;3.88,-3.45,;5.61,-5.71,;5.61,-7.25,;6.94,-4.94,;8.28,-5.71,;-1.61,1.54,;-2.94,.77,;-5.61,-3.85,;-5.61,-5.39,)| Show InChI InChI=1S/C31H39Cl2N7O5/c1-5-25(41)39-18-21(19-39)45-14-13-40-29-20(17-35-31(36-29)34-7-8-38-11-9-37(6-2)10-12-38)15-22(30(40)42)26-27(32)23(43-3)16-24(44-4)28(26)33/h5,15-17,21H,1,6-14,18-19H2,2-4H3,(H,34,35,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | 25 |
Principia Biopharma, Inc.
US Patent
| Assay Description
A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of FGFR family (FGFR1, FGFR2, FGFR3, FGFR4) kin... |
US Patent US9567334 (2017)
BindingDB Entry DOI: 10.7270/Q2XK8HKQ |
More data for this
Ligand-Target Pair | |
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM287528
(8-(2-((1-acryloylazetidin-3-yl)oxy)ethyl)-6-(2,6-d...)Show SMILES CCN1CCN(CCNc2ncc3cc(-c4c(Cl)c(OC)cc(OC)c4Cl)c(=O)n(CCOC4CN(C4)C(=O)C=C)c3n2)CC1 |(-5.61,-8.47,;-6.94,-7.7,;-6.94,-6.16,;-8.28,-5.39,;-8.28,-3.85,;-6.94,-3.08,;-6.94,-1.54,;-5.61,-.77,;-5.61,.77,;-4.28,1.54,;-4.28,3.08,;-2.94,3.85,;-1.61,3.08,;-.28,3.85,;1.06,3.08,;2.39,3.85,;2.39,5.39,;1.06,6.16,;3.72,6.16,;3.72,7.7,;5.06,8.47,;5.06,5.39,;5.06,3.85,;6.39,3.08,;7.73,3.85,;3.72,3.08,;3.72,1.54,;1.06,1.54,;2.39,.77,;-.28,.77,;-.28,-.77,;1.06,-1.54,;1.06,-3.08,;2.39,-3.85,;2.79,-5.34,;4.28,-4.94,;3.88,-3.45,;5.61,-5.71,;5.61,-7.25,;6.94,-4.94,;8.28,-5.71,;-1.61,1.54,;-2.94,.77,;-5.61,-3.85,;-5.61,-5.39,)| Show InChI InChI=1S/C31H39Cl2N7O5/c1-5-25(41)39-18-21(19-39)45-14-13-40-29-20(17-35-31(36-29)34-7-8-38-11-9-37(6-2)10-12-38)15-22(30(40)42)26-27(32)23(43-3)16-24(44-4)28(26)33/h5,15-17,21H,1,6-14,18-19H2,2-4H3,(H,34,35,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharmaceuticals Inc.
| Assay Description
A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of FGFR family (FGFR1, FGFR2, FGFR3, FGFR4) kin... |
Bioorg Med Chem Lett 19: 773-7 (2009)
BindingDB Entry DOI: 10.7270/Q2GX4DVZ |
More data for this
Ligand-Target Pair | |
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM287528
(8-(2-((1-acryloylazetidin-3-yl)oxy)ethyl)-6-(2,6-d...)Show SMILES CCN1CCN(CCNc2ncc3cc(-c4c(Cl)c(OC)cc(OC)c4Cl)c(=O)n(CCOC4CN(C4)C(=O)C=C)c3n2)CC1 |(-5.61,-8.47,;-6.94,-7.7,;-6.94,-6.16,;-8.28,-5.39,;-8.28,-3.85,;-6.94,-3.08,;-6.94,-1.54,;-5.61,-.77,;-5.61,.77,;-4.28,1.54,;-4.28,3.08,;-2.94,3.85,;-1.61,3.08,;-.28,3.85,;1.06,3.08,;2.39,3.85,;2.39,5.39,;1.06,6.16,;3.72,6.16,;3.72,7.7,;5.06,8.47,;5.06,5.39,;5.06,3.85,;6.39,3.08,;7.73,3.85,;3.72,3.08,;3.72,1.54,;1.06,1.54,;2.39,.77,;-.28,.77,;-.28,-.77,;1.06,-1.54,;1.06,-3.08,;2.39,-3.85,;2.79,-5.34,;4.28,-4.94,;3.88,-3.45,;5.61,-5.71,;5.61,-7.25,;6.94,-4.94,;8.28,-5.71,;-1.61,1.54,;-2.94,.77,;-5.61,-3.85,;-5.61,-5.39,)| Show InChI InChI=1S/C31H39Cl2N7O5/c1-5-25(41)39-18-21(19-39)45-14-13-40-29-20(17-35-31(36-29)34-7-8-38-11-9-37(6-2)10-12-38)15-22(30(40)42)26-27(32)23(43-3)16-24(44-4)28(26)33/h5,15-17,21H,1,6-14,18-19H2,2-4H3,(H,34,35,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 1.20 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of FGFR family (FGFR1, FGFR2, FGFR3, FGFR4) kin... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2DB850W |
More data for this
Ligand-Target Pair | |
Fibroblast growth factor receptor 1
(Homo sapiens (Human)) | BDBM287528
(8-(2-((1-acryloylazetidin-3-yl)oxy)ethyl)-6-(2,6-d...)Show SMILES CCN1CCN(CCNc2ncc3cc(-c4c(Cl)c(OC)cc(OC)c4Cl)c(=O)n(CCOC4CN(C4)C(=O)C=C)c3n2)CC1 |(-5.61,-8.47,;-6.94,-7.7,;-6.94,-6.16,;-8.28,-5.39,;-8.28,-3.85,;-6.94,-3.08,;-6.94,-1.54,;-5.61,-.77,;-5.61,.77,;-4.28,1.54,;-4.28,3.08,;-2.94,3.85,;-1.61,3.08,;-.28,3.85,;1.06,3.08,;2.39,3.85,;2.39,5.39,;1.06,6.16,;3.72,6.16,;3.72,7.7,;5.06,8.47,;5.06,5.39,;5.06,3.85,;6.39,3.08,;7.73,3.85,;3.72,3.08,;3.72,1.54,;1.06,1.54,;2.39,.77,;-.28,.77,;-.28,-.77,;1.06,-1.54,;1.06,-3.08,;2.39,-3.85,;2.79,-5.34,;4.28,-4.94,;3.88,-3.45,;5.61,-5.71,;5.61,-7.25,;6.94,-4.94,;8.28,-5.71,;-1.61,1.54,;-2.94,.77,;-5.61,-3.85,;-5.61,-5.39,)| Show InChI InChI=1S/C31H39Cl2N7O5/c1-5-25(41)39-18-21(19-39)45-14-13-40-29-20(17-35-31(36-29)34-7-8-38-11-9-37(6-2)10-12-38)15-22(30(40)42)26-27(32)23(43-3)16-24(44-4)28(26)33/h5,15-17,21H,1,6-14,18-19H2,2-4H3,(H,34,35,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4.20 | n/a | n/a | n/a | n/a | n/a | n/a |
PRINCIPIA BIOPHARMA, INC.
US Patent
| Assay Description
A Caliper-based kinase assay (Caliper Life Sciences, Hopkinton, Mass.) was used to measure inhibition of FGFR family (FGFR1, FGFR2, FGFR3, FGFR4) kin... |
US Patent US9815834 (2017)
BindingDB Entry DOI: 10.7270/Q2B85B83 |
More data for this
Ligand-Target Pair | |
Fibroblast growth factor receptor 2
(Homo sapiens (Human)) | BDBM287528
(8-(2-((1-acryloylazetidin-3-yl)oxy)ethyl)-6-(2,6-d...)Show SMILES CCN1CCN(CCNc2ncc3cc(-c4c(Cl)c(OC)cc(OC)c4Cl)c(=O)n(CCOC4CN(C4)C(=O)C=C)c3n2)CC1 |(-5.61,-8.47,;-6.94,-7.7,;-6.94,-6.16,;-8.28,-5.39,;-8.28,-3.85,;-6.94,-3.08,;-6.94,-1.54,;-5.61,-.77,;-5.61,.77,;-4.28,1.54,;-4.28,3.08,;-2.94,3.85,;-1.61,3.08,;-.28,3.85,;1.06,3.08,;2.39,3.85,;2.39,5.39,;1.06,6.16,;3.72,6.16,;3.72,7.7,;5.06,8.47,;5.06,5.39,;5.06,3.85,;6.39,3.08,;7.73,3.85,;3.72,3.08,;3.72,1.54,;1.06,1.54,;2.39,.77,;-.28,.77,;-.28,-.77,;1.06,-1.54,;1.06,-3.08,;2.39,-3.85,;2.79,-5.34,;4.28,-4.94,;3.88,-3.45,;5.61,-5.71,;5.61,-7.25,;6.94,-4.94,;8.28,-5.71,;-1.61,1.54,;-2.94,.77,;-5.61,-3.85,;-5.61,-5.39,)| Show InChI InChI=1S/C31H39Cl2N7O5/c1-5-25(41)39-18-21(19-39)45-14-13-40-29-20(17-35-31(36-29)34-7-8-38-11-9-37(6-2)10-12-38)15-22(30(40)42)26-27(32)23(43-3)16-24(44-4)28(26)33/h5,15-17,21H,1,6-14,18-19H2,2-4H3,(H,34,35,36) | PDB
MMDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 4.20 | n/a | n/a | n/a | n/a | n/a | n/a |
Boehringer Ingelheim Pharmaceuticals Inc.
| Assay Description
The cell-based effects of FGFR inhibitors were determined by measuring inhibition of FGFR-dependent cell line growth. The cell lines SNU-16 was used ... |
Bioorg Med Chem Lett 19: 773-7 (2009)
BindingDB Entry DOI: 10.7270/Q2GX4DVZ |
More data for this
Ligand-Target Pair | |
Search and Browse
